inositol 2,4,5-trisphosphate has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, AP; Loomis-Husselbee, JW | 1 |
| Cullen, PJ; Dawson, AP; Dreikausen, UE; Irvine, RF; Loomis-Husselbee, JW | 1 |
2 other study(ies) available for inositol 2,4,5-trisphosphate and Leukemia L 1210
| Article | Year |
|---|---|
A steady-state mechanism can account for the properties of inositol 2,4,5-trisphosphate-stimulated Ca2+ release from permeabilized L1210 cells.
Topics: Aniline Compounds; Animals; Biological Transport, Active; Buffers; Calcium; Calcium-Transporting ATPases; Cell Membrane Permeability; Fluorometry; Inositol Phosphates; Ionomycin; Leukemia L1210; Models, Biological; Terpenes; Thapsigargin; Xanthenes | 1993 |
Synergistic effects of inositol 1,3,4,5-tetrakisphosphate on inositol 2,4,5-triphosphate-stimulated Ca2+ release do not involve direct interaction of inositol 1,3,4,5-tetrakisphosphate with inositol triphosphate-binding sites.
Topics: Animals; Binding Sites; Calcium; Calcium Channels; Electroporation; Inositol 1,4,5-Trisphosphate Receptors; Inositol Phosphates; Kinetics; Leukemia L1210; Mice; Receptors, Cytoplasmic and Nuclear; Thimerosal; Tumor Cells, Cultured | 1996 |